199 related articles for article (PubMed ID: 9210691)
1. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis.
Ding JC; Bauer M; Diamond DM; Leal MA; Johnson D; Williams BK; Thomas AM; Najvar L; Graybill JR; Larsen RA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1589-93. PubMed ID: 9210691
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
Larsen RA; Bauer M; Thomas AM; Graybill JR
Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis.
Larsen RA; Bauer M; Weiner JM; Diamond DM; Leal ME; Ding JC; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1996 Sep; 40(9):2178-82. PubMed ID: 8878602
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
Diamond DM; Bauer M; Daniel BE; Leal MA; Johnson D; Williams BK; Thomas AM; Ding JC; Najvar L; Graybill JR; Larsen RA
Antimicrob Agents Chemother; 1998 Mar; 42(3):528-33. PubMed ID: 9517927
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.
Nguyen MH; Najvar LK; Yu CY; Graybill JR
Antimicrob Agents Chemother; 1997 May; 41(5):1120-3. PubMed ID: 9145879
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
[TBL] [Abstract][Full Text] [Related]
7. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA
Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
Allendoerfer R; Marquis AJ; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1991 Apr; 35(4):726-9. PubMed ID: 2069378
[TBL] [Abstract][Full Text] [Related]
13. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
[TBL] [Abstract][Full Text] [Related]
14. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
[TBL] [Abstract][Full Text] [Related]
18. Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746.
Restrepo MI; Najvar LK; Barchiesi F; Luther MF; Graybill JR
Med Mycol; 2000 Jun; 38(3):221-4. PubMed ID: 10892990
[TBL] [Abstract][Full Text] [Related]
19. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
Witt MD; Lewis RJ; Larsen RA; Milefchik EN; Leal MA; Haubrich RH; Richie JA; Edwards JE; Ghannoum MA
Clin Infect Dis; 1996 Feb; 22(2):322-8. PubMed ID: 8838190
[TBL] [Abstract][Full Text] [Related]
20. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Yao ZW; Lu X; Shen C; Lin DF
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
